Tag: Kazumi Shiosaki
New US biotech company Twentyeight-Seven Therapeutics launched with $65m funding
A new US biotech company called Twentyeight-Seven Therapeutics (28-7) has been launched in Cambridge, which will focus on modulating non-coding RNA (ncRNA) biology to develop ... Read More